GPSM1
G-protein-signaling modulator 1
Also known as: AGS3, DKFZP727I051, GPSM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86YR5
- Gene
- GPSM1
- Ensembl
- ENSG00000160360
- Chromosome
- 9
- Canonical length
- 675 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
G-protein signaling modulators (GPSMs) play diverse functional roles through their interaction with G-protein subunits. This gene encodes a receptor-independent activator of G protein signaling, which is one of several factors that influence the basal activity of G-protein signaling systems. The protein contains seven tetratricopeptide repeats in its N-terminal half and four G-protein regulatory (GPR) motifs in its C-terminal half. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
675 residues, UniProt reviewed canonical sequence.
>Q86YR5|GPSM1
1 MAGPAPPVAD ELPGPAARRL YSRMEASCLE LALEGERLCK AGDFKTGVAF FEAAVQVGTE
61 DLKTLSAIYS QLGNAYFYLK EHGRALEYHK HDLLLARTIG DRMGEAKASG NLGNTLKVLG
121 RFDEAAVCCQ RHLSIAQEQG DKVGEARALY NIGNVYHAKG KQLSWNAANA TQDPGHLPPD
181 VRETLCKASE FYERNLSLVK ELGDRAAQGR AYGNLGNTHY LLGNFTEATT FHKERLAIAK
241 EFGDKAAERR AYSNLGNAHV FLGRFDVAAE YYKKTLQLSR QLRDQAVEAQ ACYSLGNTYT
301 LLQDYERAAE YHLRHLLIAQ ELADRVGEGR ACWSLGNAYV SMGRPAQALT FAKKHLQISQ
361 EIGDRHGELT ARMNVAQLQL VLGRLTSPAA SEKPDLAGYE AQGARPKRTQ RLSAETWDLL
421 RLPLEREQNG DSHHSGDWRG PSRDSLPLPV RSRKYQEGPD AERRPREGSH SPLDSADVRV
481 HVPRTSIPRA PSSDEECFFD LLTKFQSSRM DDQRCPLDDG QAGAAEATAA PTLEDRIAQP
541 SMTASPQTEE FFDLIASSQS RRLDDQRASV GSLPGLRITH SNAGHLRGHG EPQEPGDDFF
601 NMLIKYQSSR IDDQRCPPPD VLPRGPTMPD EDFFSLIQRV QAKRMDEQRV DLAGGPEQGA
661 GGPPEPQQQC QPGASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GPSM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 106 nTPM
- heart muscle: 72 nTPM
- cerebral cortex: 42 nTPM
- pancreas: 41 nTPM
- ovary: 37 nTPM
- cervix: 35 nTPM
Single-cell type
- podocytes: 133 nCPM
- rod photoreceptor cells: 73 nCPM
- retinal pigment epithelial cells: 47 nCPM
- epididymal principal cells: 45 nCPM
- müller glia: 38 nCPM
- retinal bipolar cells: 36 nCPM
Immune cell
- T-reg: 0.5 nTPM
- intermediate monocyte: 0.4 nTPM
- memory CD4 T-cell: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
Brain region
- cerebellum: 97 nTPM
- medulla oblongata: 65 nTPM
- amygdala: 60 nTPM
- cerebral cortex: 59 nTPM
- midbrain: 55 nTPM
- basal ganglia: 55 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- establishment of mitotic spindle orientation
- negative regulation of GTPase activity
- nervous system development
- positive regulation of macroautophagy
- negative regulation of guanyl-nucleotide exchange factor activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GPSM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GPSM1 as an antibody target. Whether an autoantibody or antibody against GPSM1 could matter depends on whether native GPSM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GPSM1 is annotated at the cell surface, where native GPSM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GPSM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...